more_reports

The Latest Healthcare Services Articles from Streetwise Reports

DarioHealth AI Platform Targets 10-15% Revenue Growth from Existing Clients

  ()
DarioHealth's DarioIQ AI engine is positioned to lift B2B2C recurring revenue 10-15% from current customers while the AI healthcare market expands rapidly toward hundreds of billions.
Tags: TechnologyHealthcare ServicesLife Sciences Tools & DiagnosticsArtificial Intelligence

Digital Health Platform Lands Access to Hundreds of Thousands of Covered Lives

  ()
DarioHealth Corp. (DRIO:NASDAQ) signed a new agreement through its Amwell partnership that makes its cardiometabolic platform available to a major Arizona health insurer's ASO business, representing hundreds of thousands of covered lives.
Tags: Healthcare Services

First-of-Its-Kind US Brain Imaging Clinic Takes Delivery of Key PET Scanner

  ()
Grey Matters Health Inc. (GREY:CSE; AGW0:FRA; AGNPF:OTCQB) received its first brain-dedicated PET scanning system for its flagship Florida NovaScan Neuroimaging Clinic, which the company said will be the first U.S. facility dedicated to brain-only PET imaging for Alzheimer's disease and other neurological conditions.
Tags: Life Sciences Tools & DiagnosticsHealthcare Services

Grey Matters Health Inc. Targets Alzheimer's PET Imaging Opportunity

  ()
Grey Matters Health Inc. advances first U.S. brain-dedicated PET clinic for Alzheimer's detection amid surging diagnostics demand. Learn the key facts for investors.
Tags: Life Sciences Tools & DiagnosticsHealthcare Services

Digital Health Pioneer Targets Massive Breakthrough Chronic Care Market

  ()
AI-driven digital health solutions pioneer DarioHealth Corp. (DRIO:NASDAQ) announces a partnership that it says will give it access to a network spanning all 50 states. Find out why analysts like the direction the company is taking.
Tags: Healthcare ServicesLife Sciences Tools & Diagnostics

DarioHealth (DRIO) Expands Reach via Beluga Health Deal

  ()
DarioHealth (DRIO) integrates its AI platform with Beluga Health's network to scale provider-backed care. Discover growth catalysts, analyst targets, and investor considerations.
Tags: Healthcare ServicesLife Sciences Tools & Diagnostics

Grey Matters Health Inc. Advances US Alzheimer's Clinics

  ()
Grey Matters Health Inc. closes CA$1.25M financing to launch brain-specific PET clinics targeting the expanding Alzheimer's diagnostics market and early detection demand.
Tags: Healthcare ServicesLife Sciences Tools & Diagnostics

DarioHealth: Chronic Care Platform Drives Value

  ()
DarioHealth targets the booming digital health market with a multi-condition platform backed by 27 ADA studies. See pipeline growth, analyst targets, and key catalysts for investors.
Tags: Healthcare ServicesArtificial IntelligenceTechnologyMedical Devices

Alzheimer's Imaging Push Gains Fresh Funding as U.S. Clinic Plans Move Forward

  ()
Grey Matters Health Inc. (GREY:CSE; AGW0:FRA; AGNPF:OTCQB) closed an expanded US$1.25 million private placement and said proceeds will support its Alzheimer's disease program and planned first U.S. brain-specific neuroimaging clinic.
Tags: Healthcare ServicesLife Sciences Tools & Diagnostics

Four New ADA Studies Reveal Clinical Wins in Weight, Blood Sugar, and Healthcare Utilization

  ()
DarioHealth Corp. (DRIO:NASDAQ) presented four studies at the ADA Scientific Sessions reporting weight loss of up to 14.3%, fewer hospitalizations, and improved glycemic outcomes among high-risk cardiometabolic users of its digital health platform.
Tags: Healthcare ServicesArtificial IntelligenceTechnologyMedical Devices

Grey Matters Health Positions for Growth in Expanding Alzheimer's Diagnostics Market

  ()
Grey Matters Health advances its Alzheimer's neuroimaging strategy with fresh financing and plans for the first U.S. brain-specific PET clinic, capitalizing on rising demand for early detection tools.
Tags: Life Sciences Tools & DiagnosticsHealthcare Services

Alzheimer's Diagnostic Clinic Initiative Moves Forward After Financing Close

  ()
Grey Matters Health Inc. (GREY:CSE; AGW0:FRA; AGNPF:OTCQB) closed the first CA$500,000 tranche of a financing that the company said will support its Alzheimer's disease program and planned U.S. brain-specific neuroimaging clinic.
Tags: Life Sciences Tools & DiagnosticsHealthcare Services

From Healthcare IT Vendor to AI-Driven Holding Company

Contributed Opinion
  ()
Healthcare Triangle Inc.'s (HCTI:NASDAQ) Spanish AI acquisition delivers US$34M in revenue and a near-US$40M agentic AI run rate, while shares still trade at just 1x cash.
Tags: Healthcare Services

200 Brain PET Scans, 162 Alzheimer's Drugs: A Diagnostic Push Takes Shape

  ()
Grey Matters Health Inc. (GREY:CSE; AGW0:FRA; AGNPF:OTCQB) signed an LOI tied to a minimum of 200 brain PET scans for an Alzheimer's clinical trial while expanding its NovaScan neuroimaging strategy.
Tags: Life Sciences Tools & DiagnosticsHealthcare Services

New York Digital Health Firm Expands Reach to 116 Million Covered Lives

  ()
DarioHealth Corp. (DRIO:NASDAQ) reported first quarter 2026 results showing sequential revenue growth, lower operating expenses, expanded channel partnerships and a US$127 million commercial pipeline.
Tags: Healthcare Services

Three AI-Driven Cancer Programs Advance Toward Key 2026 Milestones

  ()
Rakovina Therapeutics Inc. (RKV:TSX.V) reported 2025 financial results and outlined progress across its kt-5000, kt-3283, and kt-2000 programs, alongside financing, leadership updates, and ongoing AI partnerships.
Tags: Healthcare ServicesBiotechnology / Pharmaceuticals

AI-Designed Cancer Drug Shows In Vivo Results, Brain Penetration

  ()
Rakovina Therapeutics Inc. (RKV:TSX.V) reported new preclinical data across two oncology programs at the AACR Annual Meeting, including ATR-mTOR inhibitor efficacy and kt-3283 formulation progress.
Tags: Healthcare ServicesBiotechnology / Pharmaceuticals

Showing Results: 26 to 42 of 42 Prev